Food, drugs, devices › Carl Zeiss Meditec AG
Device recall: ZEISS miLOOP Lens Fragmentation Device REF 303071-9090-000. Used during cataract surgery.
FDA enforcement event 89928 is a device recall by Carl Zeiss Meditec AG of Oberkochen, initiated 16 Mar 2022 and classified Class II, with 1 product record.
FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 839 device enforcement events initiated in 2022 carry the same class.
Status: Ongoing. Initiation: voluntary: firm initiated. Carl Zeiss Meditec AG has 9 enforcement events on this register, with a median of 1 product record per event.
Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.
Recalling firm
Carl Zeiss Meditec AG, Oberkochen, Germany.
Reason for recall
"High friction of the slider can cause the device to stick, or not move as intended."
Distribution
"U.S.: AL, AR, AZ, CA, CT, FL, GA, IA, IL, KS, LA, MA, MD, MI, MN, MO, MS, MT, NC, NJ, NY, OH, OR, PA, Puerto Rico, SC, TN, TX. UT, VA, WA, and WV O.U.S.: Not provided"
Product records
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| Z-1007-2022 | ZEISS miLOOP Lens Fragmentation Device REF 303071-9090-000. Used during cataract surgery. | 1225 devices | Class II | Ongoing | 4 May 2022 |
Context
Other enforcement events for Carl Zeiss Meditec AG
All 9 events for Carl Zeiss Meditec AG
Questions and answers
Why was this device recalled?
FDA's record gives the reason for recall as: "High friction of the slider can cause the device to stick, or not move as intended."
What does Class II mean?
FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Where was the product distributed?
FDA's distribution pattern field reads: "U.S.: AL, AR, AZ, CA, CT, FL, GA, IA, IL, KS, LA, MA, MD, MI, MN, MO, MS, MT, NC, NJ, NY, OH, OR, PA, Puerto Rico, SC, TN, TX. UT, VA, WA, and WV O.U.S.: Not provided"
Is the recall still ongoing?
FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.
Where does this data come from?
openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.
Provenance
Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.